166 related articles for article (PubMed ID: 3317092)
1. Rabbit nephrotoxic nephritis: effect of a thromboxane synthetase inhibitor on evolution and prostaglandin excretion.
Shinkai Y; Cameron JS
Nephron; 1987; 47(3):211-9. PubMed ID: 3317092
[TBL] [Abstract][Full Text] [Related]
2. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
Lianos EA; Andres GA; Dunn MJ
J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
[TBL] [Abstract][Full Text] [Related]
3. Trial of platelet-derived growth factor antagonist, trapidil, in accelerated nephrotoxic nephritis in the rabbit.
Shinkai Y; Cameron JS
Br J Exp Pathol; 1987 Dec; 68(6):847-52. PubMed ID: 3480754
[TBL] [Abstract][Full Text] [Related]
4. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
5. A thromboxane synthetase antagonist ameliorates progressive renal disease of Dahl-S rats.
Yamashita W; Ito Y; Weiss MA; Ooi BS; Pollak VE
Kidney Int; 1988 Jan; 33(1):77-83. PubMed ID: 2965273
[TBL] [Abstract][Full Text] [Related]
6. Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat.
Cook HT; Cattell V; Smith J; Salmon JA; Moncada S
Clin Nephrol; 1986 Oct; 26(4):195-202. PubMed ID: 3490944
[TBL] [Abstract][Full Text] [Related]
7. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
8. Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.
Nagao T; Ito M; Nagamatsu T; Suzuki Y
Eur J Pharmacol; 1994 Jul; 259(3):233-42. PubMed ID: 7982449
[TBL] [Abstract][Full Text] [Related]
9. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
Hatziantoniou C; Papanikolaou N
Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
[TBL] [Abstract][Full Text] [Related]
10. [The effects of thromboxane A2 synthetase inhibitor on chronic rejection of kidney transplantation].
Imanishi M; Ikegami M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):895-901. PubMed ID: 2402113
[TBL] [Abstract][Full Text] [Related]
11. Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
Nagao T; Nagamatsu T; Suzuki Y
Eur J Pharmacol; 1996 Nov; 316(1):73-80. PubMed ID: 8982653
[TBL] [Abstract][Full Text] [Related]
12. Effect of thromboxane inhibition on renal blood flow in dogs with complete unilateral ureteral obstruction.
Loo MH; Marion DN; Vaughan ED; Felsen D; Albanese CT
J Urol; 1986 Dec; 136(6):1343-7. PubMed ID: 3464764
[TBL] [Abstract][Full Text] [Related]
13. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Yoshida T; Ichikawa Y; Tojo T; Homma M
Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
[TBL] [Abstract][Full Text] [Related]
14. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
Morimoto K; Ikata T; Tounai T
Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
[TBL] [Abstract][Full Text] [Related]
15. Antinephritic effect of OKY-046, a thromboxane A synthetase inhibitor (1). Effects on crescentic-type anti-GBM nephritis in rats.
Nagamatsu T; Tsukushi Y; Ito M; Kondo N; Suzuki Y
Jpn J Pharmacol; 1989 Apr; 49(4):501-9. PubMed ID: 2724689
[TBL] [Abstract][Full Text] [Related]
16. The effects of aspirin and OKY-1581 on the metabolism of exogenous arachidonic acid in rat alveolar macrophages.
Punnonen K; Uotila P; Mäntylä E
Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):367-74. PubMed ID: 6431566
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
[TBL] [Abstract][Full Text] [Related]
18. Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1.
Ward PS; Fuller RW; Ritter JM; Cashman SJ; Rees AJ; Dollery CT
Br J Pharmacol; 1991 Jul; 103(3):1663-8. PubMed ID: 1933130
[TBL] [Abstract][Full Text] [Related]
19. The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction.
Loo MH; Egan D; Vaughan ED; Marion D; Felsen D; Weisman S
J Urol; 1987 Mar; 137(3):571-6. PubMed ID: 3820396
[TBL] [Abstract][Full Text] [Related]
20. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
